Nonalcoholic steatohepatitis in posttransplantation liver: Review article
Open Access
- 1 February 2018
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 64 (2) , 187-194
Abstract
Summary Introduction: Nonalcoholic steatohepatitis (NASH) associated or not with cirrhosis is the third leading indication for liver transplantation (LT) around the world. After transplants, NASH has a high prevalence and occurs as both recurrent and de novo manifestations. De novo NASH can also occur in allografts of patients transplanted for non-NASH liver disease. Objective: To evaluate recurrent or de novo NASH in post-LT patients. Method: A literature review was performed using search engines of indexed scientific material, including Medline (by PubMed), Scielo and Lilacs, to identify articles published in Portuguese and English until August 2016. Eligible studies included: place and year of publication, prevalence, clinical characteristics, risk factors and survival. Results: A total of 110 articles were identified and 63 were selected. Most of the studies evaluated recurrence and survival after LT. Survival reached 90-100% in 1 year and 52-100% in 5 years. Recurrence of NAFLD (steatosis) was described in 15-100% and NASH, in 4-71%. NAFLD and de novo NASH were observed in 18-67% and 3-17%, respectively. Metabolic syndrome, diabetes mellitus, dyslipidemia and hypertension were seen in 45-58%, 18-59%, 25-66% and 52-82%, respectively. Conclusion: After liver transplants, patients present a high prevalence of recurrent and de novo NASH. They also show a high frequence of metabolic disorders. Nevertheless, these alterations seem not to influence patient survival.Keywords
This publication has 63 references indexed in Scilit:
- Living donor liver transplantation for non‐alcoholic steatohepatitis: A single center experienceHepatology Research, 2013
- Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteersBritish Journal of Clinical Pharmacology, 2012
- Cumulative Risk of Cardiovascular Events After Orthotopic Liver TransplantationLiver Transplantation, 2011
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United StatesGastroenterology, 2011
- Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. populationHepatology, 2011
- The Influence of Nonalcoholic Fatty Liver Disease and Its Associated Comorbidities on Liver Transplant OutcomesJournal of Clinical Gastroenterology, 2011
- Outcomes of Liver Transplantation in Patients with Cirrhosis due to Nonalcoholic Steatohepatitis Versus Patients with Cirrhosis due to Alcoholic Liver DiseaseLiver Transplantation, 2009
- Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factorsJournal of Gastroenterology, 2007
- Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular eventsLiver Transplantation, 2007
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003